Acousia Therapeutics GmbH
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Holding
- Established
- 2012-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.acousia.com
Clinical Trials
2
Active:0
Completed:0
Trial Phases
2 Phases
Phase 1:1
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 2
1 (50.0%)ACOU085 for Hearing Loss Prevention in Testicular Cancer Patients Receiving Cisplatin
Phase 2
Recruiting
- Conditions
- Cisplatin-induced Hearing Loss
- Interventions
- Drug: ACOU085 (bimokalner)Drug: Placebo
- First Posted Date
- 2024-07-25
- Last Posted Date
- 2024-07-25
- Lead Sponsor
- Acousia Therapeutics GmbH
- Target Recruit Count
- 40
- Registration Number
- NCT06521190
- Locations
- 🇩🇪
Dept. of Otolaryngology - Head and Neck Surgery, Tuebingen University, Tuebingen, Baden-Wuerttemberg, Germany
🇩🇪Dept. of Otolaryngology - Head and Neck Surgery, Dresden University, Dresden, Germany
🇩🇪Dept. of Otolaryngology - Head and Neck Surgery, Essen University, Essen, Germany
News
No news found